Annual report
7376.TEDINET S100XC7N
Period2024-10-01 → 2025-09-30
Filed2025-12-23
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 86
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.5bn | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥1.3bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | −¥98m | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | −¥18m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | −¥92m | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥6m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥66m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥51m | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥113m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥104m | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥92,000 | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | −¥74m | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥6m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥45m | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥32m | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥76m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.0bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥909m | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥915m | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥830m | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥813m | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥450m | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥268m | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥569m | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥642m | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥647m | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥613m | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥575m | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥599m | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥577m | at 2024-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥599m | at 2025-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥577m | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥643m | at 2023-09-30v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥597m | at 2022-09-30v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥615m | at 2021-09-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥94m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥36m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥88m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥627,000 | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥135m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥56m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥27m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥45m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥24m | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥172m | 2024-10-01 → 2025-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥2m | 2023-10-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥3m | 2022-10-01 → 2023-09-30v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6m | 2021-10-01 → 2022-09-30v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥217m | 2020-10-01 → 2021-09-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-66.23 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.24 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.85 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.11 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.99 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.64 | 2022-10-01 → 2023-09-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.45 | 2021-10-01 → 2022-09-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.75 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥511.3 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥577.25 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥582.38 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥550.42 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥520.37 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 55.8% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.8% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -12.2% | 2024-10-01 → 2025-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.9% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2021-10-01 → 2022-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.4% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,119,740 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,119,740 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,119,740 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,113,800 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,105,520 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 242 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 232 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 200 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 191 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 173 | at 2021-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-09-30 | 3 pure |
| Otherother segments | depreciation | 2024-10-01 → 2025-09-30 | ¥8,000 |
| Otherother segments | revenue | 2024-10-01 → 2025-09-30 | ¥9m |
| Otherother segments | revenue external | 2024-10-01 → 2025-09-30 | ¥9m |
| Otherother segments | segment assets | at 2025-09-30 | ¥8m |
| Otherother segments | segment profit | 2024-10-01 → 2025-09-30 | −¥63m |
| Reconciling Itemsreconciling | capex | 2024-10-01 → 2025-09-30 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2024-10-01 → 2025-09-30 | ¥525,000 |
| Reconciling Itemsreconciling | segment assets | at 2025-09-30 | ¥759m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥217m |
| Health Care Businessreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥11m |
| Health Care Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥229,000 |
| Health Care Businessreportable segment | employees | at 2025-09-30 | 19 pure |
| Health Care Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥164m |
| Health Care Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥164m |
| Health Care Businessreportable segment | segment assets | at 2025-09-30 | ¥42m |
| Health Care Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥8m |
| IT Sales Outsourcing Businessreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥6m |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥6m |
| IT Sales Outsourcing Businessreportable segment | employees | at 2025-09-30 | 208 pure |
| IT Sales Outsourcing Businessreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥1.3bn |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥1.3bn |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2025-09-30 | ¥210m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥190m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-10-01 → 2025-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-10-01 → 2025-09-30 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-09-30 | ¥260m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-09-30 | ¥119m |
| Otherother segments | revenue | 2023-10-01 → 2024-09-30 | ¥3m |
| Otherother segments | revenue external | 2023-10-01 → 2024-09-30 | ¥3m |
| Otherother segments | segment assets | at 2024-09-30 | ¥490,000 |
| Otherother segments | segment profit | 2023-10-01 → 2024-09-30 | −¥21m |
| Reconciling Itemsreconciling | capex | 2023-10-01 → 2024-09-30 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥410,000 |
| Reconciling Itemsreconciling | segment assets | at 2024-09-30 | ¥698m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥189m |
| Health Care Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥1m |
| Health Care Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥227,000 |
| Health Care Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥156m |
| Health Care Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥156m |
| Health Care Businessreportable segment | segment assets | at 2024-09-30 | ¥35m |
| Health Care Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥18m |
| IT Sales Outsourcing Businessreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥6m |
| IT Sales Outsourcing Businessreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥5m |
| IT Sales Outsourcing Businessreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| IT Sales Outsourcing Businessreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥1.2bn |
| IT Sales Outsourcing Businessreportable segment | segment assets | at 2024-09-30 | ¥176m |
| IT Sales Outsourcing Businessreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥210m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-10-01 → 2024-09-30 | ¥7m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-10-01 → 2024-09-30 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-09-30 | ¥212m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-09-30 | ¥171m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 961
| Item | Context | Value | Unit |
|---|---|---|---|
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2024-10-01 | |
| Current period end date | FilingDateInstant | 2025-09-30 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2025-09-30 | |
| Previous fiscal year start date | FilingDateInstant | 2023-10-01 | |
| Comparative period end date | FilingDateInstant | 2024-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2024-09-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Reference to other information risk management | FilingDateInstant | Original text (Japanese)第２ 事業の状況 ３ 事業等のリスク (3)②人材の獲得、確保、育成について | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所(グロース市場) | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、株主としての権利内容に制限のない標準となる株式であります。なお、単元株式数は100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |